Return to site

Medixine wins Mahindra Group’s 200 000 euro innovation prize

Press Release

The Indian Mahindra Group held its annual M101 Senior Leaders Conference this year in Helsinki. Prime minister Juha Sipilä participated in the event. Mahindra Group is a 19 B USD federation of companies having 200,000 employees out of which 1400 in Finland.

The M101 conference was an opportunity for Mahindra to tap into the dynamic Finnish innovation and start-up eco-system with Avatar Hunt, a unique search for the next big idea, a new and radical ‘avatar’ of business with potential for future growth. “Our intent is to leverage the strengths of this unique eco-system to help us discover the next big ideas and business models which will help us leverage the forces of disruption to create new opportunities for the Group in the future,” said Anand Mahindra, Chairman, Mahindra Group.

Seven Finnish startups and growth companies had been selected to the competition from a group of 74 pre-screened companies. Medixine won the competition and received a prize and an investment of 200,000€ from Mr Anand Mahindra.

“We are proud and honoured of this prize reflecting the hard work that the Medixine staff has done to create a global opportunity for Finnish healthcare technology”, said Tapio Jokinen, CEO of Medixine.

About Mahindra

The Mahindra Group is a USD 19 billion federation of companies that enables people to rise through innovative mobility solutions, driving rural prosperity, enhancing urban living, nurturing new businesses and fostering communities. It has a leadership position in utility vehicles, information technology, financial services and vacation ownership in India and is the world’s largest tractor company, by volume. It also enjoys a strong presence in agribusiness, components, commercial vehicles, consulting services, energy, industrial equipment, logistics, real estate, steel, aerospace, defence and two wheelers. Headquartered in India, Mahindra employs over 200,000 people across 100 countries.

About Medixine

Medixine provides solutions that enable smooth collaboration between health care providers, patients and family members. They provide tools for connecting different data sources and optimizing care processes. With their help, our partners and customers can enhance the quality of care and achieve cost savings. Medixine is based in Helsinki, Finland.

Vendep Capital

Vendep Capital Fund invests primarily in Finnish startups offering software to B2B customers. In April 2017, Vendep Capital launched a new €40 million fund aimed at SaaS startups. The fund was raised from Finnish private and institutional investors such as Tesi (Finnish Industry Investment Ltd) and The Finnish Innovation Fund Sitra. The fund may make investments alone or as part of a syndicate.

All Posts

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly